Effects of risperidone on affective symptoms in patients with schizophrenia

International Clinical Psychopharmacology

Volumn 15, Issue 6, 2000, Pages 343-349

  Peuskens, J ^a   De Smedt, C ^a   Lemmens, P ^b   Van Baelen, B ^b  

^a University Centre St Jozef   (Belgium)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Affective symptoms; Risperidone; Schizophrenia

Indexed keywords

HALOPERIDOL; RISPERIDONE;

ADOLESCENT; ADULT; AGED; ALEXITHYMIA; ANXIETY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GUILT; HOSTILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MOOD; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SCHIZOIDISM; SCHIZOPHRENIA; SELF CONTROL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; PATIENT DROPOUTS; PSYCHIATRIC STATUS RATING SCALES; RANDOMIZED CONTROLLED TRIALS; RISPERIDONE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0033759894     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(98)80414-8     Document Type: Article

References (38)

1. Practice guidelines for the treatment of patients with bipolar disorder
2. Negative v positive schizophrenia: Definition and validation
3. Long-term treatment of mood disorders in schizophrenia
4. Can risperidone be antidepressive and also inhibit aggression?
5. Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients
6. Affective disorders and tardive dyskinesia
7. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
8. Risperidone versus haloperidol in the treatment of chronic schizophrenia in inpatients: A multicentre, double-blind, comparative study
9. Molecular pathology of schizophrenia: More than one disease process?
10. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder
11. Long-term risperidone treatment in bipolar disorder: 6-Month follow-up
12. Adjunctive treatments in bipolar and schizoaffective disorder: Comparison of risperidone, conventional neuroleptics and clonazepam with mood stabilizers
13. Depression and social adjustment among chronic schizophrenia out-patients
14. Risperidone treatment of refractory acute mania
15. 2-adrecoceptor antagonism
16. Relapse in schizophrenia
17. Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome: A functional approach
18. Risperidone in the treatment of affective illness and obsessive compulsive disorder
19. Tardive dyskinesia
20. The complex problem of treatment
21. Tardive dyskinesia: Prevalence, incidence, and risk factors
22. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
23. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders
24. Effect of neuroleptic treatment on depressive symptoms in acute schizophrenic episodes
25. Dimensions positives et negatives dans les schizophrenies
26. Five factor model of schizophrenia: Replication across samples
27. Principal component analysis of the Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia
28. Risperidone in the treatment of schizophrenia
29. The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the North American Trial
30. Risperidone versus haloperidol in the treatment of chronic schizophrenic patients: A parallel-group, double-blind comparative trial
31. Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome
32. Depressive symptoms in acute schizophrenic inpatients
33. Risperidone in the treatment of patients with chronic schizophrenia: A multi-national, multi-centre, double-blind, parallel-group study versus haloperidol
34. Risperidone therapy in treatment refractory acute bipolar and schizoaffective mania
35. Comparison of patients with early, typical-, and late-onset affective psychosis
36. Risperidone in HIV-related manic psychosis
37. Risperidone in the treatment of mania